Accredited Investors — NI 45-106

Infrastructure Alpha: Bio Terrava Technology Platform

Bio Terrava Technologies Inc. is a Stittsville, Ontario-based cleantech company developing an interlocking vertical technology stack for industrial wastewater treatment and nutrient recovery — backed by 36 years of founder engineering expertise, four provisional patents, and active university validation partnerships.

Securities Notice: Access to our investor data room is restricted to Accredited Investors as defined under National Instrument 45-106. This page contains forward-looking statements. Actual results may differ materially.
Request Data Room Access

The Investment Thesis

Industrial wastewater is the largest underserved infrastructure market in North America. Regulatory pressure is accelerating. Bio Terrava sits at the intersection of compliance urgency and resource recovery.

Regulatory Tailwinds

Health Canada 2024 PFAS limits, CCME 2023 Biosolids update, WSER amendments, and MECP tightening create immediate compliance demand. The market is not speculative — it is mandated.

Vertical Technology Stack

Four interlocking provisional patents filed April 2026: BOFS valorization → VASCGBC-M composite media → Terra BPC biosolid conversion → integrated system. Each layer generates independent revenue.

Revenue-Generating Consulting

Unlike pre-revenue deep-tech ventures, Bio Terrava operates an active P.Eng. consulting practice today — generating cash flow while the technology platform matures toward TRL 6 and commercial deployment.

Patent Portfolio — Four Provisional Patents Filed April 2026

Patent 1 Provisional Filed

BOFS Valorization Process

Conversion of Basic Oxygen Furnace Slag (BOFS) from steel EAF operations into engineered mineral composite input for downstream treatment media. Conversion deadline: April 2027.

Patent 2 Provisional Filed

VASCGBC-M Composite Media

Vertically-Aligned Structured Composite Granular Biochar-Ceramic-Mineral (VASCGBC-M). Phosphorus loading capacity 10–12× conventional biochar. Root-exudate-triggered nutrient release.

Patent 3 Provisional Filed

Terra BPC Thermochemical Process

Bio-Pyrolysis Conversion of biosolids and organic waste via co-pyrolysis with BOFS at optimized temperature ranges. Three-output circular process: upgraded wood vinegar + Fe/Mg/Ca/P-doped biochar + mineral-enriched syngas.

Patent 4 Provisional Filed

Integrated Combination System

End-to-end integrated system combining BOFS input, VASCGBC-M production, Terra BPC conversion, and THPP nutrient extraction into a single circular treatment platform.

Technology Readiness Level Roadmap

TRL 4

Lab Validation

IN PROGRESS

Target: Q4 2026

University of Western Ontario — Dr. Franco, PI. Ontario Centre of Innovation co-funded.

TRL 5

Integrated Pilot

PLANNED

Target: Q3 2027

Pilot-scale integrated system validation. Target: Ontario industrial partner site.

TRL 6

Field Pilot

KEY MILESTONE

Target: Q1 2028

First commercial-scale field pilot. Capital raise milestone event.

TRL 7

Commercial Demo

TARGET

Target: Q3 2028

Full commercial demonstration. Revenue from first technology license or asset sale.

Three Revenue Streams

Service

P.Eng. Consulting (Active Now)

Industrial wastewater compliance consulting, WWTP expansion studies, biosolids management, and PFAS assessment — generating revenue today using founder credentials. Generating immediate consulting revenue while the technology platform matures.

Product

VASCGBC-M Biochar (TRL 4→6)

Premium engineered biochar for organic greenhouse operators, regenerative agriculture, and precision horticulture. Price premium: $1,500–$3,000/tonne vs. $400–$800 for conventional biochar.

Carbon

Carbon Credits (Post-TRL 6)

Verified carbon sequestration credits from biochar soil application and biosolid diversion from landfill. Certification via recognized GHG registry post-pilot validation.

University Validation Partnership

University of Western Ontario

Dr. Franco, Principal Investigator. Two active Scopes of Work: SOW-2026-001 (VASCGBC-M) and SOW-2026-002 (Terra BPC). Governed by NDA, Sponsored Research Agreement, Material Transfer Agreement, and IP Assignment Agreement.

OCI Co-funding

Ontario Centre of Innovation funding supports the university validation program — non-dilutive co-investment in TRL 4→5 advancement.

IPON

Intellectual Property Ontario is supporting funding for conversion of our four provisional patent applications into full utility patents ahead of the April 2027 deadline.

Request Investor Data Room Access

Restricted to Accredited Investors under NI 45-106. We will verify eligibility before granting access.

NI 45-106 Notice: By submitting this form, you confirm you are an Accredited Investor as defined under National Instrument 45-106 of Canadian securities law. This does not constitute an offer of securities.